Characterizing miR-20a-3p Expression in the Progression of Oral Squamous Cell Carcinoma

Abstract

Aim:

This study aims to elucidate the role of miR-20a-3p in the inhibition of tumor suppressor genes, thereby enhancing the development and advancement of oral squamous cell carcinoma (OSCC) by fostering the proliferation and viability of tumor cells. Additionally, the study seeks to evaluate the potential of miR-20a-3p as a prognostic biomarker for more effective treatment strategies in OSCC patients.

Materials and Methods:

This observational, analytical study utilized a convenience sampling method, involving a total of 63 OSCC biopsy samples and corresponding nontumor oral tissues from the same patients. The expression levels of miR-20a-3p were quantified using quantitative real-time polymerase chain reaction. Clinical information, including tumor stage, and grade was obtained. Statistical analysis included unpaired Student’s t tests to compare miR-20a-3p expression levels between normal and OSCC samples, and one-way ANOVA to compare expression across different grades and stages of the tumor, using SPSS version 19.

Results:

Our findings demonstrate that miR-20a-3p expression was significantly downregulated in OSCC samples compared to healthy controls (p < .001). Additionally, we observed a correlation between miR-20a-3p downregulation and OSCC histological grade and staging. miR-20a-3p expression levels were significantly different across different grades of OSCC, particularly between well-differentiated squamous cell carcinoma (WDSCC) and poorly differentiated squamous cell carcinoma (PDSCC) (p < .006) and moderately differentiated squamous cell carcinoma and PDSCC (p < .008). There was a significant difference in miR-20a-3p expression between normal tissues and Stage II (p < .006) and Stage IV (p < .001) OSCC.

Conclusion:

The study confirms that miR-20a-3p acts as a tumor suppressor in OSCC and holds potential as a biomarker for prognosis and personalized treatment strategies. miR-20a-3p expression is significantly reduced in OSCC tissues compared to normal tissues, and its levels vary with tumor grade and stage. These findings underscore the importance of further research into miRNAs as therapeutic targets.

Keywords

Oral squamous cell carcinoma Oral cancer Tumor suppressor miRNA miR-20a

Get full access to this article

View all access options for this article.

References

Avs

, Pandi

, Kannan

, . RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma. Clin Oral Investig 2023; 27(11): 6961–6969. https://doi.org/10.1007/s00784-023-05316-4

Warnakulasuriya

. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol, 2009; 45: 309–316. https://doi.org/10.1016/j.oraloncology.2008.06.002

Nakamura

, Hiyake

, Hamada

, . Circulating microRNA panel as a potential novel biomarker for oral squamous cell carcinoma diagnosis. Cancers, 2021; 13: 449. https://doi.org/10.3390/cancers13030449

Kowalski

and Sanabria

Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital, 2007; 27: 113–117. PMID: 17883186.

Ananya

, Pandi

, Kannan

, . DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma. J Stomatol Oral Maxillofac Surg, 2024; 125(4): 101734. https://doi.org/10.1016/j.jormas.2023.101734

Gopalakrishnan

, Pandi

, Arumugam

, . MicroRNAs targeting CDKN2A gene as a potential prognostic marker in head and neck squamous cell carcinoma. Mol Biol Res Commun, 2024; 13(1): 21–27. https://doi.org/10.22099/mbrc.2023.48081.1853

Thomaidou

, Batsaki

, Adamaki

, . Promising biomarkers in head and neck cancer: the most clinically important miRNAs. Int J Mol Sci, 2022; 23: 8257. https://doi.org/10.3390/ijms23158257

Moridikia

, Mirzaei

, Sahebkar

, . MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol, 2018; 233: 901–913. https://doi.org/10.1002/jcp.25801

Otmani

and Lewalle

Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol, 2021; 11: 708765. https://doi.org/10.3389%2Ffonc.2021.708765

10.

Zhang

, Wang

, Sun

, . Change of circulating and tissue-based miR-20a in human cancers and associated prognostic implication: a systematic review and meta-analysis. BioMed Res Int, 2018; 1–14. https://doi.org/10.1155/2018/6124927

11.

Rizzo

, Mariani

, Pitto

, . miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence. J Cell Mol Med, 2010; 14: 2633–2640. https://doi.org/10.1111/j.1582-4934.2010.01173.x

12.

, Shen

, Du

, . A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. Cell Death Differ, 2018; 25: 406–420. https://doi.org/10.1038/cdd.2017.176

13.

Saravanan

, Islam

, Thirugnanasambantham

, . In silico identification of human miR 3654 and its targets revealed its involvement in prostate cancer progression. MicroRNA, 2016; 5: 140–145. https://doi.org/10.2174/2211536605666160610094230

14.

, Zhang

, Yu

, . Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci, 2013; 14: 16226–16239. https://doi.org/10.3390/ijms140816226

15.

Krishnan

, Mani

, Sivakumar

, . Expression and methylation of circulating microRNA-510 in essential hypertension. Hypertens Res, 2017; 40: 361. https://doi.org/10.1038/hr.2016.147

16.

, Zhang

, Yu

, . Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci, 2013; 14: 16226–16239. https://doi.org/10.3390/ijms140816226

17.

Qiang

, Zhang

, Liu

, . miR-20a promotes prostate cancer invasion and migration through targeting ABL2. J Cell Biochem, 2014; 115: 1269–1276. https://doi.org/10.1002/jcb.24778

18.

Flynt

and Lai

. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet, 2008; 9: 831–842. https://doi.org/10.1038/nrg2455

19.

Lodish

, Zhou

, Liu

, . Micromanagement of the immune system by microRNAs. Nat Rev Immunol, 2008; 8: 120–130. https://doi.org/10.1038/nri2252

20.

Chang

, Liu

, Yang

, . MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol, 2013; 59: 518–527. https://doi.org/10.1016/j.jhep.2013.04.034

21.

Fan

, Huang

, Gu

, . Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res, 2013; 32: 21. https://doi.org/10.1186/1756-9966-32-21

22.

Chang

, Yang

, Li

, . MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol, 2013; 49: 923–931. https://doi.org/10.1016/j.oraloncology.2013.03.430

23.

Zhang

, Xiang

, Han

, . Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. Int J Clin Exp Pathol, 2015; 8: 11446. PMID: 26617873.

24.

Krutovskikh

and Herceg

Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. BioEssays: News Rev Mol, Cell Dev Biol, 2010; 32: 894–904. https://doi.org/10.1002/bies.201000040

25.

Thomas

, Selvakumar

, Preethi

, . miRNA-20a: a dual regulator of cell migration and apoptosis in oral squamous cell carcinoma—an in vitro study. J Orofac Sci, 2023; 15: 167–174. https://doi.org/10.4103/jofs.jofs_330_23

26.

, Pang

, Liu

, . Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21. Oncol Rep, 2018; 40: 1138–1146. https://doi.org/10.3892/or.2018.6477

27.

, Ge

, Xu

. HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a. Tumor Biol, 2016; 37: 9433–9440. https://doi.org/10.1007/s13277-016-4817-4

28.

Moody

, Dvoretskiy

, An

, . The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: a systematic review and meta-analysis. Cancers, 2019; 11: 1111. https://doi.org/10.3390/cancers11081111

29.

Coutinho-Camillo

, Lourenço

, de Araújo Lima

, . Expression of apoptosis-regulating miRNAs and target mRNAs in oral squamous cell carcinoma. Cancer Genet, 2015; 208: 382–389. https://doi.org/10.1016/j.cancergen.2015.04.004

30.

, Meng

, Qu

, . Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. World J Gastroenterol, 2015; 21: 4660. https://doi.org/10.3748/wjg.v21.i15.4660

31.

Geng

, Fan

, Zhang

, . Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Respir Res, 2014; 15: 1–9. https://doi.org/10.1186/s12931-014-0149-3

32.

Huang

, Wu

, Xiang

, . Regulatory mechanism of miR-20a-5p expression in Cancer. Cell Death Discov, 2022; 8: 262. https://doi.org/10.1038/s41420-022-01005-5

33.

Zhang

, Zhang

, . Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis. Sci Rep, 2017; 7: 8375. https://doi.org/10.1038/s41598-017-08349-4